Pharma executive Martin Shkreli arrested on fraud charges

The charges deal with Shkreli’s time as manager for hedge fund MSMB Capital Management and as chief executive of biopharmaceutical company Retrophin.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.